Epicardial Ablation of Ventricular Tachycardia in Ischemic Cardiomyopathy

Area of Science:

• Cardiology
• Electrophysiology
• Cardiac Surgery

Background:

• Ventricular tachycardia (VT) is a common complication of ischemic cardiomyopathy.
• Myocardial scar tissue from infarction creates reentry circuits, leading to VT.
• Endocardial ablation is standard, but epicardial VT substrate may require alternative approaches.

Purpose of the Study:

• To evaluate the role and outcomes of epicardial catheter ablation for ventricular tachycardia in ischemic cardiomyopathy.
• To determine predictors of epicardial substrate location.
• To assess the safety and efficacy of percutaneous epicardial ablation in specific patient populations.

Main Methods:

• Review of patients undergoing catheter ablation for VT in ischemic cardiomyopathy.
• Correlation of imaging findings (e.g., transmural infarction) with substrate location (endocardial vs. epicardial).
• Analysis of procedural success, complications, and long-term outcomes for endocardial and epicardial ablation strategies.

Main Results:

• Epicardial ablation is necessary when VT substrate is located near the epicardium, often associated with near transmural infarction.
• Imaging suggesting transmural infarction can predict epicardial substrate.
• Percutaneous epicardial ablation offers improved outcomes in selected patients but is contraindicated in those with prior coronary artery bypass grafting due to increased risk.

Conclusions:

• Epicardial catheter ablation is a valuable strategy for managing refractory ventricular tachycardia in ischemic cardiomyopathy when the substrate is epicardial.
• Pre-procedural imaging is crucial for identifying patients likely to benefit from epicardial ablation.
• Careful patient selection is paramount, particularly regarding prior coronary artery bypass grafting, to mitigate procedural risks.